Posted on 289
Eurofins Technologies continues to develop a range of diagnostic solutions for COVID-19, particularly in response to the threat of emerging mutations. Today, we announce the launch of two new products: GSD NovaPrime
® Plus SARS-CoV-2, a PCR test which can detect, in one reaction, key mutations of variants of concern, present for example in the UK variant; and GSD NovaType Select L452R SARS-CoV-2 (RUO) the first test of its type able to detect critical variants such as the Indian, USA and Californian variants. Eurofins Technologies will continue to invest in R&D to develop further reliable, high-quality testing solutions for the SARS-CoV-2 virus and its variants.
대웅제약 메디톡스 美 신규 소송, 관할 없는 것 알면서 제기한 것 : 100세시대의 동반자 브릿지경제
viva100.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from viva100.com Daily Mail and Mail on Sunday newspapers.
메디톡스, 美서 대웅제약 관련 신규 소송 2건 추가 제기
viva100.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from viva100.com Daily Mail and Mail on Sunday newspapers.